1975
DOI: 10.1111/j.1398-9995.1975.tb00204.x
|View full text |Cite
|
Sign up to set email alerts
|

Transfer Factor as an Additional Therapeutic Agent in Mycosis Fungoides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
5
0

Year Published

1975
1975
1985
1985

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 8 publications
0
5
0
Order By: Relevance
“…The clinical observation of increased skin augment delayed hypersensitivity reactions in reactivity and lymphokine production after the skin (10). DLE therapy in patients with DLE therapy (7,11), and augmentation of evidence of depressed cell-mediated immune DNA synthesis following in vivo (23) and in vitro reactitivity have shown promising clinical ef-(1) administration possibly reflect that DLE fects (7,19,20,23,25,26). However, the modulates the lymphocyte cyclic nucleotide syschemical constitution of transfer factor in DLE tem.…”
mentioning
confidence: 99%
“…The clinical observation of increased skin augment delayed hypersensitivity reactions in reactivity and lymphokine production after the skin (10). DLE therapy in patients with DLE therapy (7,11), and augmentation of evidence of depressed cell-mediated immune DNA synthesis following in vivo (23) and in vitro reactitivity have shown promising clinical ef-(1) administration possibly reflect that DLE fects (7,19,20,23,25,26). However, the modulates the lymphocyte cyclic nucleotide syschemical constitution of transfer factor in DLE tem.…”
mentioning
confidence: 99%
“…and this could have bear ing on therapy. Our patient with the lowest T-cell value also had a poor response in lyrnphocyte trans formation tests (14). This patient was treated with transfer factor as an additional t herapeutic agent when he did not respond to conventional treatment with topical nitrogen mustard, methotrexate, X-rays and grenz rays.…”
Section: Commentsmentioning
confidence: 73%
“…Also, we could not demonstrate any correlation between the presence of "migration-inhibition-factor" in serum and the increased inhibition of leucocyte migration occasionally seen after addition of PPD to tbe cultures. TF, prepared in the same way as in this trial, has earlier been used successfully in our department for tbe treatment of mycosis fungoides (21) and in a patient witb generalized M. avium infection (17). However, in the present study no lasting effect witb TF treatment was recorded in the in vitro investigations and only minor clinical improvements were obtained.…”
Section: Discussionmentioning
confidence: 99%
“…at intervals of a to 4 weeks. TF was prepared from pooled buffy coat cells from normal blood donors (21).…”
Section: Transfer Factor Therapymentioning
confidence: 99%
See 1 more Smart Citation